01 Mar Coave Therapeutics
Rodolphe Clerval, CEO
April 20 | 1:45pm | Gaudi 2 Ballroom
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.